Cigna Group (CI) Expected to Announce Earnings on Thursday

Cigna Group (NYSE:CI) is expected to announce its Q4 2025 results before the market opens on Thursday, February 5th. Analysts expect the company to announce earnings of $7.90 per share and revenue of $69.5253 billion for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 5, 2026 at 8:30 AM ET.

Cigna Group Stock Performance

Shares of CI opened at $271.13 on Tuesday. The firm has a market capitalization of $72.43 billion, a P/E ratio of 11.96, a P/E/G ratio of 0.97 and a beta of 0.27. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The stock has a 50 day moving average price of $274.55 and a two-hundred day moving average price of $284.19. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76.

Wall Street Analyst Weigh In

CI has been the subject of a number of analyst reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th. Sanford C. Bernstein reiterated a “market perform” rating and issued a $307.00 target price on shares of Cigna Group in a report on Tuesday, January 6th. UBS Group set a $294.00 price target on shares of Cigna Group in a research report on Wednesday, November 12th. Guggenheim reaffirmed a “buy” rating and issued a $318.00 price objective on shares of Cigna Group in a research report on Monday. Finally, Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $323.84.

Institutional Investors Weigh In On Cigna Group

Several large investors have recently added to or reduced their stakes in the company. Invesco Ltd. increased its holdings in Cigna Group by 17.2% during the 3rd quarter. Invesco Ltd. now owns 1,900,502 shares of the health services provider’s stock worth $547,820,000 after acquiring an additional 279,564 shares during the period. Amundi grew its position in shares of Cigna Group by 14.3% during the 3rd quarter. Amundi now owns 1,570,065 shares of the health services provider’s stock valued at $475,212,000 after purchasing an additional 196,613 shares in the last quarter. Raymond James Financial Inc. increased its holdings in shares of Cigna Group by 16.2% in the third quarter. Raymond James Financial Inc. now owns 1,322,897 shares of the health services provider’s stock worth $381,325,000 after purchasing an additional 184,158 shares during the period. Man Group plc raised its position in shares of Cigna Group by 9.5% in the third quarter. Man Group plc now owns 582,895 shares of the health services provider’s stock worth $168,019,000 after buying an additional 50,712 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co raised its position in shares of Cigna Group by 1.8% in the third quarter. CANADA LIFE ASSURANCE Co now owns 402,543 shares of the health services provider’s stock worth $115,295,000 after buying an additional 7,259 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.